MDM2 inhibitor APG-115 exerts potent antitumor activity and synergizes with standard-of-care agents in preclinical acute myeloid leukemia models

por Fang, Douglas D., Tang, Qiuqiong, Kong, Yanhui, Rong, Tao, Wang, Qixin, Li, Na, Fang, Xu, Gu, Jiaxing, Xiong, Dengkun, Yin, Yan, Deng, Jing, Yang, Dajun, Zhai, Yifan
Publicado 2021

Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models

por Fang, Douglas D., Tao, Ran, Wang, Guangfeng, Li, Yuanbao, Zhang, Kaixiang, Xu, Chunhua, Zhai, Guoqin, Wang, Qixin, Wang, Jingwen, Tang, Chunyang, Min, Ping, Xiong, Dengkun, Chen, Jianyong, Wang, Shaomeng, Yang, Dajun, Zhai, Yifan
Publicado 2022